support
In drug
development, there are different ways to arrive at your destination
: choosing the right route is vital
Strategic product development underpins the
future of the pharmaceutical industry - but its a process that is
changing fast. In particular, the advent of combinatorial chemistry
coupled with the incisive demands of the regulatory authorities, has
increased the sheer volume of data involved and intensified the
burden of its management.
However,
this is information that can be handled and screened so that lead
candidates for new products can still be identified within
reasonable timescales.
Once the
candidate list has been streamlined, its become more vital than ever
before to determine accurately, and without delay, the further work
required accompanied by timeframe and financial considerations.
Sequani compiles such prospectuses and plans, identifying turning
points and pitfalls.
As the whole
process has become more involved, its become vital to pinpoint the
critical times at which the decision can be made to forge ahead - or
to re-assess the project. Knowing when to carry on.
Pharmaceutical companies worldwide spend an
increasing proportion of their R&D budgets with contract research
organisations like Sequani because they appreciate superior value
for money, greater flexibility and speed of response..... they like
they way we turn data into decisions and help define the best route
to take. |
